Sleep abnormalities associated with major depressive disorders include an early onset of rapid eye movement (REM) sleep, increased awakenings, reduced slow-wave sleep and increased light, non-restorative sleep. This paper presents a review of the effects of antidepressants on sleep electroencephalogram (EEG) in depression, including tricyclics (TCAs), and selective serotonin re-uptake inhibitors (SSRIs). Studies of the effects of nefazodone, a phenylpiperazine agent that has dual action on serotonin (5-HT1A re-uptake inhibition and 5-HT2 antagonism), are also included. In contrast to TCAs and SSRIs, nefazodone is a non-sedating antidepressant that improves sleep consolidation. Nefazodone also has little effect on REM latency or on total REM time, as reported for trimipramine, iprindole, moclobemide and bupropion. These findings suggest that antidepressant efficacy is not solely tied to REM sleep suppression.
ArmitageR. (1994). Sleep: biological rhythms and human performance. In RamachandranV.S. (ed.), Encyclopedia of human behaviour, Vol 4. Academic Press Inc.San Diego, CA, pp. 205–211
2.
ArmitageR. (1995). Microarchitectural findings in sleep EEG in depression: diagnostic implications.Biol Psychiatr37: 72–84.
3.
ArmitageR., RushA.J., TrivediM., CainJ., RoffwargH.P. (1994). The effects of nefazodone on sleep architecture in depression.Neuropsychopharmacology10: 123–127.
4.
ArmitageR., TrivediM., RushA.L. (1995). Fluoxetine and oculomotor activity during sleep in depressed patients.Neuropsychopharmacology12: 159–165.
CarskadonM.A., DementW.C. (1989). Normal human sleep: an overview. In KrygerM.H., RothT., DementW.C. (eds), Principles and practice of sleep medicine.WB SaundersPhiladelphia, PA, pp. 3–13
7.
CoulterD.M., PillansP. I. (1995). Fluoxetine and extrapyramidal side effects.Am J Psychiatr152: 122–125.
DunleavyD.L., BrezinovaV., OswaldI., MacLeanA.W., TinkerM. (1972). Changes during weeks in effects of tricyclic drugs on the human sleeping brain.Br J Psychiatr28: 353–356.
10.
EisonA.S., EisonM.S., TorrenteJ.R., WrightR.N., YoccaF.D. (1990). Nefazodone: preclinical pharmacology of a new antidepressnt.Psychochopharmacol Bull26: 311–315.
11.
HamiltonM. (1960). A rating scale for depression.J Neurol Neurosurg Psychiatr23: 56–62.
12.
HendrickseW.A., RoffwargH.P., GrannemannB.D., OrsulakP.J., ArmitageR., CainJ.W., BattagliaJ., DebusJ.R., RushA.J. (1994). The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study.Neuropsychopharmacology10: 85–91.
13.
JonesB.E. (1991). Paradoxical sleep and its chemical/structural substrates in the brain.Neuroscience40: 637–656.
14.
JouvetM., DeNoyerM., KitahamaK., SallonanonM. (1989). Slow wave sleep and indolamines. A hypothalamic target. In WauquierA., DugovicC. (eds), Slow wave sleep, physiologic and functional aspects.Raven PressNew York, pp. 91–108
15.
KeckP.E., HudsonJ.I., DorseyC.M., MathesonJ.K., CampbellP. I. (1990). Increased eye movements during non-REM sleep in fluoxetine-induced insomnia.Sleep Res19: 66
16.
KupferD.J., EhlersC.L., PollockB.G., NathanS., PerelJ. M. (1989). Clomipramine and EEG sleep in depression.Psychiatr Res30.165–180
17.
KupferD.J., PerelJ.M., PollockB.G., NathanR.S., GrochocinskiV.J., WilsonM.J., McEachranA. B. (1991). Fluvoxamine versus desipramine: comparative polysomnographic effects.Biol Psychiatr20: 23–40.
18.
MontiJ.M. (1989). Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patientsBr J Psychiatr155 (Suppl 6): 61–65
19.
MouretJ., LemoineP., MinuitM.P., BenkelfatC., RenardetM. (1988). Effects of trazodone on the sleep of depressed subjects, a polysomnographic study.Psychophannacology95: 537–543.
20.
NofzingerE.A., ReynoldsC.F.III, ThaseM.E., FrankE., JenningsJ.R., FasiczkaA.L., SullivanL.R., KupferD. J. (1995). REM sleep enhancement by bupropion in depressed men.Am J Psychiatr152: 274–276.
21.
OswaldI., AdamK. (1986). Effects of paroxetine on human sleep.Br J Clin Pharmacol22: 97–99.
22.
RechtschaffenA., KalesA. (1968). A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects.Government Printing Office, National Institute of Health, Washington, DC, U.S. Publication No. 204
23.
ReynoldsC.F., KupferD. J. (1987). Sleep research in affective illness: State of the art circa 1987.Sleep10: 199–215.
24.
RushA.J., CainJ.W., RaeseJ., StewartR.S., WallerD.A., DebusJ. R. (1991). Neurobiological bases for psychiatric disorders. In RosenbergR.N. (ed.), Comprehensive neurology.Raven PressNew York, pp. 555–603.
25.
SaletuB., FreyR., KrupkaM., AndererP., GrunbergerJ., SeeW.R. (1991). Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities.Sleep14: 439–447.
26.
SchenckC.H., MahowaldM.W., KimS.W., O'ConnorK.A., HurwitzT.D. (1992). Prominent eye movements during non-REM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive–compulsive disorder.Sleep15: 226–235.
27.
SchenckG.K., FillerW., RanftW., ZerbinD. (1981). Double-blind comparisons of a selective serotonin reuptake inhibitor, zimelidine, and placebo on quantified EEG parameters and psychological variables.Acta Psychiatr Scand Suppl290: 303–313.
28.
ShipleyJ.E., KupferD.J., DealyR.S., GriffinS.J., CobleP.A., McEachranA.B., GrochocinskiV. J. (1984). Differential effects of amitriptyline and of zimelidine on the sleep electroencephalogram of depressed patients.Clin Pharmacol Ther36: 251–259.
29.
ShipleyJ.E., KupferD.J., GriffinS.J., DealyR.S., CobleP.A., McEachranA.B., GrochocinskiV.J., UlrichR., PerelJ. M. (1985). Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients.Psychophannacology85: 14–22.
30.
StanerL., KempenaersC., SimonnetM-P, FransoletL., MendlewiczJ. (1992). 5-HT2 receptor antagonism and slow-wave sleep in major depression.Acta Psychiatr Scand86: 133–137.
31.
VogelG.W., BuffensteinA., MinterK., HennesseyA. (1990). Drug effects on REM sleep and on endogenous depression.Neurosci Biobehav Rev14: 49–63.
